Tools for Anti-Inflammatory Drug Design: In Vitro Models of Leukocyte Migration

Emma Frow, Jill Reckless, David J. Grainger

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Inhibiting leukocyte recruitment is now a major focus in the design of novel anti-inflammatory drugs. Following the identification of lead compounds from conventional high-throughput screens using appropriate receptors or enzymes, it is important to validate the action of the compounds in a suitable in vitro model of leukocyte migration. Here, we review a range of different experimental approaches to modelling leukocyte migration, and identify the multi-well filter migration assay as the best compromise between the amount of resources required to screen multiple compounds and the amount of information gained about the effects of the compounds on cell movement behavior. However, there are pitfalls in the interpretation of data obtained using the multi-well filter migration assay, which arise from the imperfect correlation between the number of cells undergoing migration and the inhibitory activity of the test substances. We examine a number of such pitfalls and provide practical approaches to mitigate these problems as far as possible. We recommend a general strategy for screening inhibitors of cell migration using in vitro functional assays. While being more resource intensive than surrogate measures such as calcium flux, functional approaches nevertheless provide superior correlations with anti-inflammatory activity in vivo.

Original languageEnglish (US)
Pages (from-to)267-298
Number of pages32
JournalMedicinal Research Reviews
Volume24
Issue number3
StatePublished - May 2004
Externally publishedYes

Fingerprint

Drug Design
Cell Movement
Assays
Leukocytes
Anti-Inflammatory Agents
Pharmaceutical Preparations
Lead compounds
Screening
Cells
Throughput
Fluxes
Calcium
Enzymes
In Vitro Techniques

Keywords

  • Chemotaxis
  • Filter migration assay
  • Inflammation
  • Inhibitor
  • Leukocyte

ASJC Scopus subject areas

  • Organic Chemistry
  • Medicine(all)
  • Pharmacology

Cite this

Tools for Anti-Inflammatory Drug Design : In Vitro Models of Leukocyte Migration. / Frow, Emma; Reckless, Jill; Grainger, David J.

In: Medicinal Research Reviews, Vol. 24, No. 3, 05.2004, p. 267-298.

Research output: Contribution to journalArticle

Frow, Emma ; Reckless, Jill ; Grainger, David J. / Tools for Anti-Inflammatory Drug Design : In Vitro Models of Leukocyte Migration. In: Medicinal Research Reviews. 2004 ; Vol. 24, No. 3. pp. 267-298.
@article{334d86004bd540b199556eedf34329b0,
title = "Tools for Anti-Inflammatory Drug Design: In Vitro Models of Leukocyte Migration",
abstract = "Inhibiting leukocyte recruitment is now a major focus in the design of novel anti-inflammatory drugs. Following the identification of lead compounds from conventional high-throughput screens using appropriate receptors or enzymes, it is important to validate the action of the compounds in a suitable in vitro model of leukocyte migration. Here, we review a range of different experimental approaches to modelling leukocyte migration, and identify the multi-well filter migration assay as the best compromise between the amount of resources required to screen multiple compounds and the amount of information gained about the effects of the compounds on cell movement behavior. However, there are pitfalls in the interpretation of data obtained using the multi-well filter migration assay, which arise from the imperfect correlation between the number of cells undergoing migration and the inhibitory activity of the test substances. We examine a number of such pitfalls and provide practical approaches to mitigate these problems as far as possible. We recommend a general strategy for screening inhibitors of cell migration using in vitro functional assays. While being more resource intensive than surrogate measures such as calcium flux, functional approaches nevertheless provide superior correlations with anti-inflammatory activity in vivo.",
keywords = "Chemotaxis, Filter migration assay, Inflammation, Inhibitor, Leukocyte",
author = "Emma Frow and Jill Reckless and Grainger, {David J.}",
year = "2004",
month = "5",
language = "English (US)",
volume = "24",
pages = "267--298",
journal = "Medicinal Research Reviews",
issn = "0198-6325",
publisher = "John Wiley and Sons Inc.",
number = "3",

}

TY - JOUR

T1 - Tools for Anti-Inflammatory Drug Design

T2 - In Vitro Models of Leukocyte Migration

AU - Frow, Emma

AU - Reckless, Jill

AU - Grainger, David J.

PY - 2004/5

Y1 - 2004/5

N2 - Inhibiting leukocyte recruitment is now a major focus in the design of novel anti-inflammatory drugs. Following the identification of lead compounds from conventional high-throughput screens using appropriate receptors or enzymes, it is important to validate the action of the compounds in a suitable in vitro model of leukocyte migration. Here, we review a range of different experimental approaches to modelling leukocyte migration, and identify the multi-well filter migration assay as the best compromise between the amount of resources required to screen multiple compounds and the amount of information gained about the effects of the compounds on cell movement behavior. However, there are pitfalls in the interpretation of data obtained using the multi-well filter migration assay, which arise from the imperfect correlation between the number of cells undergoing migration and the inhibitory activity of the test substances. We examine a number of such pitfalls and provide practical approaches to mitigate these problems as far as possible. We recommend a general strategy for screening inhibitors of cell migration using in vitro functional assays. While being more resource intensive than surrogate measures such as calcium flux, functional approaches nevertheless provide superior correlations with anti-inflammatory activity in vivo.

AB - Inhibiting leukocyte recruitment is now a major focus in the design of novel anti-inflammatory drugs. Following the identification of lead compounds from conventional high-throughput screens using appropriate receptors or enzymes, it is important to validate the action of the compounds in a suitable in vitro model of leukocyte migration. Here, we review a range of different experimental approaches to modelling leukocyte migration, and identify the multi-well filter migration assay as the best compromise between the amount of resources required to screen multiple compounds and the amount of information gained about the effects of the compounds on cell movement behavior. However, there are pitfalls in the interpretation of data obtained using the multi-well filter migration assay, which arise from the imperfect correlation between the number of cells undergoing migration and the inhibitory activity of the test substances. We examine a number of such pitfalls and provide practical approaches to mitigate these problems as far as possible. We recommend a general strategy for screening inhibitors of cell migration using in vitro functional assays. While being more resource intensive than surrogate measures such as calcium flux, functional approaches nevertheless provide superior correlations with anti-inflammatory activity in vivo.

KW - Chemotaxis

KW - Filter migration assay

KW - Inflammation

KW - Inhibitor

KW - Leukocyte

UR - http://www.scopus.com/inward/record.url?scp=1842852975&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1842852975&partnerID=8YFLogxK

M3 - Article

C2 - 14994365

AN - SCOPUS:1842852975

VL - 24

SP - 267

EP - 298

JO - Medicinal Research Reviews

JF - Medicinal Research Reviews

SN - 0198-6325

IS - 3

ER -